| 201 |
15890569 | Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. | 2005 Jun 1 |
1 |
| 202 |
15987992 | New approaches to enhance chemotherapy in SCCHN. | 2005 |
1 |
| 203 |
15999529 | siRNA is not more effective than a first generation antisense oligonucleotide when directed against EGFR in the treatment of PC-3 prostate cancer. | 2005 Jul-Aug |
2 |
| 204 |
16000298 | Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. | 2005 Sep 2 |
1 |
| 205 |
16037687 | Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro. | 2005 |
1 |
| 206 |
16061661 | Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer. | 2005 Aug 1 |
2 |
| 207 |
14704124 | Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells. | 2004 Jan |
2 |
| 208 |
15182504 | [Effects of RNA interference on epidermal growth factor receptor expression in SPC-A-1 cells]. | 2004 May |
2 |
| 209 |
15733386 | [Effect of RNA interference on EGF receptor expression of non-small-cell lung cancer A549 cell line]. | 2004 Dec |
1 |
| 210 |
12610866 | [Molecular-targeted therapy]. | 2003 Feb |
1 |
| 211 |
12888834 | Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil. | 2003 Aug 4 |
1 |
| 212 |
12894544 | Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents. | 2003 May-Jun |
2 |
| 213 |
12483525 | Cisplatin-induced activation of the EGF receptor. | 2002 Dec 12 |
15 |
| 214 |
11350885 | Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. | 2001 May |
1 |
| 215 |
11391854 | Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway. | 2001 May |
1 |
| 216 |
11410862 | Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. | 2001 Jul 15 |
1 |
| 217 |
11459199 | Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines. | 2001 Jun |
4 |
| 218 |
11565870 | Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor. | 2001 Sep |
7 |
| 219 |
11604556 | Evidence for epidermal growth factor receptor-enhanced chemosensitivity in combinations of cisplatin and the new irreversible tyrosine kinase inhibitor CI-1033. | 2001 Sep |
3 |
| 220 |
10601618 | Concordance between tumour cell activation by epidermal growth factor and alteration of cell sensitivity to cisplatin and lymphokine-activated killer cell activity. | 2000 Jan-Feb |
2 |
| 221 |
10629487 | Antiepidermal growth factor receptor antibodies augment cytotoxicity of chemotherapeutic agents on squamous cell carcinoma cell lines. | 2000 Jan |
4 |
| 222 |
10761709 | Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells. | 2000 Feb |
3 |
| 223 |
10803405 | Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression. | 2000 Jan |
1 |
| 224 |
10213228 | Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. | 1999 Apr |
1 |
| 225 |
10226546 | Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells. | 1999 Jan-Feb |
1 |
| 226 |
9588705 | Differential expression of epidermal growth factor receptor in human head and neck cancers. | 1998 Jul |
1 |
| 227 |
9060958 | Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA. | 1997 Mar 5 |
6 |
| 228 |
9494544 | Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines. | 1997 Nov-Dec |
2 |
| 229 |
8758793 | [Effect of antisense c-erbB2 on biologic behaviour and chemotherapeutic drug sensitivity in human ovarian cancer cells]. | 1996 Mar |
1 |
| 230 |
9816301 | Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. | 1996 Aug |
1 |
| 231 |
21541503 | Anti-tumor and cell cycle responses in KB cells treated with a chimeric anti-EGFR monoclonal antibody in combination with cisplatin. | 1996 Aug |
2 |
| 232 |
7847819 | Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells. | 1994 Sep-Oct |
2 |